Results 101 to 110 of about 191,956 (212)

Analysis of neutralizing antibodies to COVID-19 inactivated or subunit recombinant vaccines in hospitalized patients with liver dysfunction. [PDF]

Front Immunol, 2023
Li H, Li S, Xu P, Wang X, Deng H, Lei Y, Zhong S.   +6 more
europepmc   +1 more source

Simultaneous construction strategy using two types of fluorescent markers for HVT vector vaccine against infectious bursal disease and H9N2 avian influenza virus by NHEJ-CRISPR/Cas9

Frontiers in Veterinary Science
Recently, herpesvirus of turkeys (HVT), which was initially employed as a vaccine against Marek’s disease (MD), has been shown to be a highly effective viral vector for producing recombinant vaccines that can simultaneously express the protective ...
Jun-Feng Zhang, Jun-Feng Zhang, Ke Shang, Ke Shang, Sang-Won Kim, Jong-Yeol Park, Bai Wei, Hyung-Kwan Jang, Hyung-Kwan Jang, Min Kang, Min Kang, Se-Yeoun Cha   +11 more
doaj   +1 more source

CRISPR/Cas System Toward the Development of Next-Generation Recombinant Vaccines: Current Scenario and Future Prospects. [PDF]

Arab J Sci Eng, 2023
Naeem M, Alkhodairy HF, Ashraf I, Khalil AB.   +3 more
europepmc   +1 more source

SARS CoV subunit vaccine: Antibodymediated neutralisation and enhancement [PDF]

, 2012
1. A SARS vaccine was produced based on recombinant native full-length Spike-protein trimers (triSpike) and efficient establishment of a vaccination procedure in rodents. 2.
Altmeyer, R, Bruzzone, R, Cheung, CY, Daeron, M, Dutry, I, Escriou, N, Jaume, M, Kam, YW, Kien, F, Li, PH, Nal, B, Peiris, JSM, Roberts, A, Subbarao, K, Yip, MS   +14 more
core   +1 more source

Current Status of Poultry Recombinant Virus Vector Vaccine Development

Vaccines
Inactivated and live attenuated vaccines are the mainstays of preventing viral poultry diseases. However, the development of recombinant DNA technology in recent years has enabled the generation of recombinant virus vector vaccines, which have the ...
Haoran Wang, Jiaxin Tian, Jing Zhao, Ye Zhao, Huiming Yang, Guozhong Zhang   +5 more
doaj   +1 more source

Evolution Bites - Timeworn Inefficacious Snakebite Therapy in the Era of Recombinant Vaccines. [PDF]

Indian Pediatr, 2021
Kaur N, Iyer A, Sunagar K.
europepmc   +1 more source

Protective vaccination in the horse against _Streptococcus equi_ with recombinant antigens [PDF]

, 2009
_Streptococcus equi_ subspecies _equi_ (_S. equi_) is a clonal, equine host-adapted pathogen of global importance that causes a highly contagious suppurative lymphodendopathy of the head and neck, more commonly known as Strangles.
Andrew Waller, Bengt Guss, Carl Robinson, Jan-Ingmar Flock, Ken Smith, Lars Frykberg, Margareta Flock   +6 more
core   +1 more source

Comparative Safety and Efficacy of Commercial Porcine Vaccines Against Mycoplasma hyopneumoniae and Porcine Circovirus Type 2 (PCV2)

Animals
Mycoplasma hyopneumoniae (Mhyo) and porcine circovirus type 2 (PCV2) infections cause enormous economic losses in the swine production sector. Vaccination remains the most effective strategy against the complex clinical entities caused by these pathogens.
Meritxell Simon-Grifé, Alexandra Moros, Cecilia Pedernera, Ester Puigvert, Lucía Acal, Elena Plantalech, Mercè Roca, Jordi Montané, Ricard March, Marta Sitjà   +9 more
doaj   +1 more source

Identification of Leptospiral Protein Antigens Recognized by WC1⁺ γδ T Cell Subsets as Target for Development of Recombinant Vaccines. [PDF]

Infect Immun, 2022
Teixeira AF, Gillespie A, Yirsaw A, Britton E, Telfer JC, Nascimento ALTO, Baldwin CL.   +6 more
europepmc   +1 more source

Securing poultry production from the ever-present Eimeria challenge [PDF]

, 2013
Blake, D P, Tomley, F M
core   +2 more sources